Mission
Through strategic, innovative, inclusive, and creative communications and marketing, UCM serves as the central strategic voice of UMBC. Our work elevates UMBC’s brand and reputation, drives enrollment, engages alumni and donors, and positions UMBC as a driver of economic growth in our region and beyond. We ensure our public mission remains visible, valued, and supported.
Our teams use creative strategies, storytelling, and campaigns to help achieve the university’s strategic goals. Contact us to learn how we can help you get the visibility and results you want.
Vision
UCM will be seen as the central trusted resource that sets the UMBC standard for innovative and strategic marketing and communications practice. Through our bold and collaborative work, by 2030, UMBC will be a nationally recognized, distinct leader in public higher education excellence and community impact.
Commitments
- We build and promote a strong brand
- We are a digital-first team
- We enhance reputation and visibility across all audiences and stakeholders
- We amplify university strategic goals
- We drive innovation in marketing and communications
- We impact enrollment
Recently Published
From UMBC News and Magazine
Freeman Hrabowski to continue higher ed leadership as inaugural ACE Centennial Fellow after retirement as UMBC president
Posted: June 24, 2022, 1:30 PM
Coppersmith is America East “Woman of the Year”—the first in UMBC history
Posted: June 24, 2022, 8:43 AM
Only about 1 in 5 engineering degrees go to women
Posted: June 23, 2022, 11:24 AM
What’s it Like When “Take Your Dog to Work Day” Is Every Day?
Posted: June 23, 2022, 9:55 AM
Rethinking collaborative public humanities research in New Orleans and Baltimore
Posted: June 17, 2022, 7:52 AM
UMBC’s 2022 Fulbright student scholars will travel the world to explore difficult questions
Posted: June 16, 2022, 3:23 PM
A Season of Change for the CADVC
Posted: June 15, 2022, 2:21 PM
Simons Foundation provides $2.5M to support UMBC Meyerhoff Scholars, plans New York replication
Posted: June 10, 2022, 4:19 PM
Creating new antiviral drugs: Katherine Seley-Radtke’s innovative “fleximer” research to receive $3.5M from NIH
Posted: June 10, 2022, 3:38 PM
- Go to page 1
- …
- Go to page 103
- Go to page 104
- Go to page 105
- Go to page 106
- Go to page 107
- …
- Go to page 697